Kaizen Advisory’s LeMaitre Vascular LMAT Stock Holding History

Kaizen Advisory’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$548K	Sell	23,201 -4,422	-16%	-$121K	0.38%	113
2018 Q3	$1.07M	Buy	+27,623	New	+$995K	0.56%	39

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Kaizen Advisory's LMAT Position: Q4 2018 in Review

Kaizen Advisory reduced its LeMaitre Vascular (LMAT) stake by 16% in Q4 2018, selling an estimated $121K and leaving 23,201 shares worth $548K. The position accounts for 0.38% of the portfolio, ranked #113.

Kaizen Advisory first reported a position in LMAT in Q3 2018 and has held it in 2 quarters since. The position peaked at $1.07M in Q3 2018. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

Kaizen Advisory held 23,201 shares of LeMaitre Vascular worth $548K as of Q4 2018.
Kaizen Advisory sold 4,422 LeMaitre Vascular shares in Q4 2018, an estimated $121K.
LeMaitre Vascular made up 0.38% of Kaizen Advisory's portfolio in Q4 2018, its #113 holding.
Kaizen Advisory first reported a position in LeMaitre Vascular in Q3 2018 and has held it in 2 quarters since.
Kaizen Advisory's LeMaitre Vascular position peaked at $1.07M in Q3 2018.
139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.